US Patent 9765066 Selective HDAC1 and HDAC2 inhibitors
Patent 9765066 was granted and assigned to Regenacy Pharmaceuticals on September, 2017 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 9765066 Selective HDAC1 and HDAC2 inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
